The Patent Finder

Mina Therapeutics Limited

10 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Sep 15, 2027
    The maintenance fee for Albumin production and cell proliferation (US 9,284,553) comes due Sep 15, 2027. Unpaid by Mar 15, 2028, it lapses early.
  • 2 fees due Oct 23 to 28, 2027 · next Oct 23

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 21, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,774,331Methods of inducing insulin production
In force
 · USPTO record
In forceUSPTO record
US 8,916,534Methods of Inducing Insulin Production
In force
 · High confidence
In forceHigh confidence
US 9,745,579Albumin production and cell proliferation
In force
 · USPTO record
In forceUSPTO record
US 10,704,044Albumin production and cell proliferation
In force
 · USPTO record
In forceUSPTO record
US 9,284,553Albumin production and cell proliferation
In force
 · USPTO record
In forceUSPTO record
US 10,202,601C/Ebp Alpha Short Activating RNA Compositions and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,633,659C/EBPα short activating RNA compositions and methods of use
In force
 · USPTO record
In forceUSPTO record
US 10,912,790C/EBP alpha saRNA compositions and methods of use
In force
 · USPTO record
In forceUSPTO record
US 11,965,163HNF4a saRNA compositions and methods of use
In force
 · USPTO record
In forceUSPTO record
US 11,566,246SIRT1-SARNA Compositions and Methods of Use
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 6 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 4 abandoned · 20 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited